Com base no CPA 2026/0098 – Avalglucosidase Alfa 100 mg Pó
TED · 628833-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Cencora 3Pl Portugal, S.A. | 2 | €823,396 | 2026-10-27 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
| Takeda Farmacêuticos Portugal, Lda | 1 | €1,828,250 | 2026-07-17 |
| Cencora 3PL Portugal, S.A. | 1 | €1,435,097 | 2026-07-20 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição de Avalglucosidase Alfa 100 mg Pó
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-04 | 2026/0098 - AVALGLUCOSIDASE ALFA [100 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-08-11 | 2026/0098 - AGALSIDASE ALFA [1 MG/ML 3,5 ML F/AMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-09-14 | Aquisição de Antitripsina Alfa-1 1000 Mg Pó Sol Inj Fr IV, de Antitripsina Alfa -1 5000 Mg Pó Sol Inj Fr IV e de Antitripsina Alfa -1 4000 Mg Pó Sol Inj Fr IV | Unidade Local de Saúde de Coimbra, EPE PT | 92% |
| 2026-08-11 | 2026/0098 - ALGLUCOSIDASE ALFA [50 MG F/AMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-10-26 | C/ BASE NO CPA 2026_6 - CABOZANTINIB 20 MG COMP + TEPOTINIB 225 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 91% |
| 2026-08-17 | C/ BASE NO CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 91% |